Evolution of delayed resistance to immunotherapy in a melanoma responder-Reference-Cited by-同舟云学术

Evolution of delayed resistance to immunotherapy in a melanoma responder

Published:2021-05-03 Issue:6 Volume:27 Page:985-992
ISSN:1078-8956
Container-title:Nature Medicine
language:en
Short-container-title:Nat Med

Author:

Liu David,Lin Jia-Ren^ORCID,Robitschek Emily J.,Kasumova Gyulnara G.,Heyde Alex,Shi Alvin,Kraya Adam,Zhang Gao,Moll Tabea,Frederick Dennie T.,Chen Yu-An^ORCID,Wang Shu,Schapiro Denis^ORCID,Ho Li-Lun,Bi Kevin,Sahu Avinash,Mei Shaolin,Miao Benchun,Sharova Tatyana,Alvarez-Breckenridge Christopher,Stocking Jackson H.^ORCID,Kim Tommy,Fadden Riley,Lawrence Donald,Hoang Mai P.^ORCID,Cahill Daniel P.,Malehmir Mohsen^ORCID,Nowak Martin A.^ORCID,Brastianos Priscilla K.^ORCID,Lian Christine G.,Ruppin Eytan^ORCID,Izar Benjamin^ORCID,Herlyn Meenhard^ORCID,Van Allen Eliezer M.^ORCID,Nathanson Katherine^ORCID,Flaherty Keith T.,Sullivan Ryan J.^ORCID,Kellis Manolis^ORCID,Sorger Peter K.^ORCID,Boland Genevieve M.^ORCID

Funder

Dr. Miriam and Sheldon G. Adelson Medical Research Foundation

U.S. Department of Defense

Conquer Cancer Foundation

Damon Runyon Cancer Research Foundation

Society for Immunotherapy of Cancer

U.S. Department of Health & Human Services | National Institutes of Health

Doris Duke Charitable Foundation

Broad Institute

Publisher

Springer Science and Business Media LLC

Subject